⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TTRX News
Turn Therapeutics Inc. Common Stock
Form 8-K
sec.gov
TTRX
Form 8-K
sec.gov
TTRX
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
globenewswire.com
NBP
TTRX
Form 8-K
sec.gov
TTRX
Form 8-K
sec.gov
TTRX
Form 8-K
sec.gov
TTRX
Form 8-K
sec.gov
TTRX
Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026
businesswire.com
TTRX
Form 8-K
sec.gov
TTRX
Turn Therapeutics Announces Final Stage 2 Design and Data-Driven Expansion of GX-03 Phase 2 Program in Atopic Dermatitis
businesswire.com
TTRX